The response of uterine fibroids to GnRH-agonist treatment can be predicted in most cases after one month

A conservative approach to the management of uterine leiomyoma: Pituitary desensitization by a luteinizing hormone-releasing hormone analogue

Marco Filicori, Deborah A. Hall, Jacquelyn S. Loughlin et al. · American Journal of Obstetrics and Gynecology · 1983 · 198 citations

Pituitary Desensitization, Uterine Fibroids, Pituitary Gland +8

A randomized, placebo-controlled, double-blind study evaluating the efficacy of leuprolide acetate depot in the treatment of uterine leiomyomata

Andrew J. Friedman, Debra Harrison-Atlas, Robert L. Barbieri et al. · Fertility and Sterility · 1989 · 167 citations

Uterine Leiomyomata, Hormonal Contraceptive, Uterine Fibroids +8

Doppler assessment of uterine blood flow changes in patients with fibroids receiving the gonadotropin-releasing hormone agonist Buserelin

W Matta, Isobil Stabile, Robert W. Shaw et al. · Fertility and Sterility · 1988 · 155 citations

Infertility, Hormonal Contraceptive, Uterine Fibroids +8

Efficacy and safety considerations in women with uterine leiomyomas treated with gonadotropin-releasing hormone agonists: The estrogen threshold hypothesis

Andrew J. Friedman, Susan M. Lobel, Mitchell S. Rein et al. · American Journal of Obstetrics and Gynecology · 1990 · 148 citations

Uterine Leiomyomas, Uterine Fibroids, Gynecological Surgery +8

A randomized trial evaluating leuprolide acetate before hysterectomy as treatment for leiomyomas

Thomas G. Stovall, Frank W. Ling · American Journal of Obstetrics and Gynecology · 1991 · 101 citations

Leuprolide Acetate, Gynecologic Surgery, Surgical Oncology +7